Available from Radcliffe publishing: http://www.radcliffe-oxford.com/books/bookdetail.aspx?ISBN=184619184X
Published in association with the Office of Health Economics this book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies and pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including Ames, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade.
This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade. – Martina Garau and Jorge Mestre-Ferrandiz in the Introduction
Contents – Pricing and reimbursement policies in France: current and future trends; Pricing and reimbursement policies in Germany: current and future trends; Pricing and reimbursement policies in UK: a current and future trends; Pricing and reimbursement policies in Italy: current and future trends; Pricing and reimbursement policies in Spain: current and future trends; Overview
Contributors: Claude Le Pen, J-Mattias von der Schulenburg, Martina Garau, Adrian Towse, Livio Garattini, Joan Costa-i-Font, Patricia Danzon
2007 144 pages Paperback
ISBN-10 1 84619 184 X ISBN-13 9781846191848